Vivani Medical Stock
Vivani Medical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Adam Mendelsohn
- Employees
- 42
- Market cap
- $101 M
- IPO
- 19/11/2014
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with…
Vivani Medical stock: price history
1D
-2.6%
1W
-10.4%
1M
-8.2%
6M
-16.4%
YTD
-8.9%
1Y
-24.3%
2Y
-9.7%
5Y
-87.2%
10Y
-98.3%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~11% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Vivani Medical
Analyst assessment of Vivani Medical
PRICE TARGET LOW
US$4.00
CONSENSUS
US$4.00
MEDIAN
US$4.00
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 31/03/2026
Vivani Medical stock metrics
P/E
-3.2
P/B
5.14
EV/EBITDA
-3.69
RETURN ON EQUITY
-33.6%
NET MARGIN
0.0%
DEBT/EQUITY
0.94
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
42.0%
FLOAT SHARES
37,842,581
AVG. DAILY VOLUME (30D)
212,093
Insider transactions (SEC)
Williams Gregg
Williams Gregg
Williams Gregg
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Vivani Medical stock
What does Vivani Medical do?
Vivani Medical, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Adam Mendelsohn, the company employs around 42 people.
The IPO was on 19/11/2014; the stock trades on NASDAQ under the ticker VANI.
What do analysts say about Vivani Medical stock?
2 analysts rate the stock, the consensus is Buy (as of 31/03/2026).
The average price target is US$4.00, ranging from US$4.00 to US$4.00, with a median of US$4.00.
This is an external assessment, not a statement by Market Jury.
When does Vivani Medical report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly -11% stronger than usual.
Does Vivani Medical pay a dividend?
No, Vivani Medical currently does not pay a dividend.
Which stocks are comparable to Vivani Medical?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Vivani Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Vivani Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.